Opsona Therapeutics logo
  • home
  • sitemap


  • about us
  • our research
  • investors
  • partnering
  • news
  • careers
  • contact us

news





home > News >


News


DateTitle
13-11-2009Opsona Therapeutics Appoints CFO & Senior Business Development Executive to Management Team
09-10-2009Opsona Therapeutics Founder Awarded Prestigious Boyle Medal
18-05-2009Roche Venture Fund, Enterprise Ireland Commit €3.3 m To Opsona Series B Financing
04-03-2009OPSONA & LONZA enter into manufacturing agreement for the production of a monoclonal antibody OPN-305 developed by OPSONA Therapeutics Ltd.
22-02-2009OPSONA, CSL Form Vaccine Adjuvant R&D Collaboration Targeting Infectious Diseases And Oncology
18-02-2009OPSONA Therapeutics closes €18M funding
02-02-2009Antitope Ltd & Opsona Therapeutics Ltd announce successful Composite Human Antibody project
24-11-2008Opsona Therapeutics Appoints new VP of Research
19-05-2008Opsona's CEO is a finalist for the 2008 Ernst & Young Entrepreneur of the Year competition.
15-05-2008Opsona Receives Milestone Payments Under Wyeth Collaboration
21-11-2007Opsona Therapeutics In-Licenses Novel Anti-inflammatory Molecule from Nestlé
15-03-2006Opsona and Phylogica enter into a drug discovery collaboration
13-02-2006Opsona Therapeutics Announces a Collaboration with Wyeth on Toll-Like Receptors
24-02-2005Opsona completes €6.6m financing agreement
01-01-2005Opsona Therapeutics appoints CFO & Senior Business Development Executive to Management Team


  • Privacy Statement
  • Registration
  • Contact us
  • Disclaimer

© Opsona Therapeutics 2009 website by Strata3